Chronic Lymphocytic Leukemia Study
A CLL Research Consortium (CRC) Phase II Study of Kinetic Biomarker for Chronic Lymphocytic (CLL) Prognosis
Protocol ID
05.06.067
Protocol Description
In patients with leukemia, blood cells (both normal cells and leukemic cells) are produced in the bone marrow to replace cells that have died or been removed. This process of replacement is called cell turnover. This study will look at the cell turnover of leukemia cells in patients with chronic lymphocytic leukemia using a method to measure the production and destruction rates of cells.
Eligibility Criteria
Patients with chronic lymphocytic leukemia
Primary Investigator(s)
- Kanti Rai, MD
Contact Information
Last Update
March 26, 2010How did I get to this page?
Persistent Navigation
- Home
- About Us
- Centers of Excellence
- Our Laboratories
- Research Topics
-
Clinical Trials
- Addiction
- Aging
- Allergies
- Arthritis
- Autoimmune Disease
- Blood Disorders
- Cancer
- Children's Health
- Circulation
- Diabetes
- Ear & Hearing
- Eyes
- Gastrointestinal/Hepatitis
- Genetics
- Heart
- HIV
- Infectious Diseases
- Joints
- Kidney
- Lung
- Lupus
- Men's Health
- Mental Health
- Neurosciences
- Radiation Medicine
- Recruitment Registry
- Skin
- Sleep Disorders
- Smoking
- Urinary Tract
- Weight Control
- Women's Health
- Academics
- Resources for Investigators
- Upcoming Events